ACADIA PHARMACEUTICALS INC. Increase (Decrease) in Inventories
ACADIA PHARMACEUTICALS INC. (ACAD) reported Increase (Decrease) in Inventories of -$3.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$3.90M, a 195.05% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$78.00K, a 100.75% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $4.89M, a 10.58% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.25M, a 193.76% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2025 was $18.20M, a 63.28% decline from fiscal 2024.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2024 was $49.55M, a 72.00% increase from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2023 was $28.81M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2022 was -$2.42M, a 157.36% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$3.98M 10-Q · filed 2026-08-05 | $917.00K derived: sum of 3 quarters · filed 2026-08-05 | -$331.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$78.00K 10-Q · filed 2026-05-07 | $4.81M derived: sum of 2 quarters · filed 2026-05-07 | $3.57M derived: sum of 3 quarters · filed 2026-05-07 | $7.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.64M derived: sum of 2 quarters · filed 2026-02-26 | $7.74M derived: sum of 3 quarters · filed 2026-08-05 | $18.20M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.85M derived: sum of 2 quarters · filed 2026-08-05 | $13.30M 10-Q · filed 2025-11-06 | $17.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $14.55M 10-Q · filed 2026-08-05 | $18.98M derived: sum of 3 quarters · filed 2026-08-05 | $20.31M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.45M 10-Q · filed 2026-05-07 | $14.88M derived: sum of 2 quarters · filed 2026-05-07 | $16.21M derived: sum of 3 quarters · filed 2026-05-07 | $43.35M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.75M derived: sum of 2 quarters · filed 2026-02-26 | $32.90M derived: sum of 3 quarters · filed 2026-02-26 | $49.55M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $28.48M derived: sum of 2 quarters · filed 2025-11-06 | $45.13M 10-Q · filed 2025-11-06 | $60.19M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $27.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $43.80M 10-Q · filed 2025-08-07 | $58.86M derived: sum of 3 quarters · filed 2026-02-26 | $70.08M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $16.65M 10-Q · filed 2025-05-08 | $31.71M derived: sum of 2 quarters · filed 2026-02-26 | $42.94M derived: sum of 3 quarters · filed 2026-02-26 | $45.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $15.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.29M derived: sum of 2 quarters · filed 2026-02-26 | $29.29M derived: sum of 3 quarters · filed 2026-02-26 | $28.81M 10-K · filed 2026-02-26 |
| 2023-09-30 | $11.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $14.22M derived: sum of 2 quarters · filed 2024-11-07 | $13.74M 10-Q · filed 2024-11-07 | $13.43M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.52M 10-Q · filed 2024-08-07 | $2.21M derived: sum of 3 quarters · filed 2025-02-27 | $1.57M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$481.00K 10-Q · filed 2024-05-09 | -$791.00K derived: sum of 2 quarters · filed 2025-02-27 | -$1.43M derived: sum of 3 quarters · filed 2025-02-27 | -$2.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$950.00K derived: sum of 2 quarters · filed 2025-02-27 | -$1.58M derived: sum of 3 quarters · filed 2025-02-27 | -$2.42M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$640.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$1.27M derived: sum of 2 quarters · filed 2023-11-03 | -$2.10M 10-Q · filed 2023-11-03 | -$2.32M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$632.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.47M 10-Q · filed 2023-08-03 | -$1.68M derived: sum of 3 quarters · filed 2024-02-28 | $1.87M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$833.00K 10-Q · filed 2023-05-08 | -$1.05M derived: sum of 2 quarters · filed 2024-02-28 | $2.50M derived: sum of 3 quarters · filed 2024-02-28 | $2.88M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.33M derived: sum of 2 quarters · filed 2024-02-28 | $3.72M derived: sum of 3 quarters · filed 2024-02-28 | $4.21M 10-K · filed 2024-02-28 |
| 2021-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.94M derived: sum of 2 quarters · filed 2022-11-03 | $4.43M 10-Q · filed 2022-11-03 | $6.08M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $878.00K 10-Q · filed 2022-08-09 | $2.53M derived: sum of 3 quarters · filed 2023-02-28 | $4.18M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $492.00K 10-Q · filed 2022-05-05 | $2.14M derived: sum of 2 quarters · filed 2023-02-28 | $3.79M derived: sum of 3 quarters · filed 2023-02-28 | $3.77M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.30M derived: sum of 2 quarters · filed 2023-02-28 | $3.28M derived: sum of 3 quarters · filed 2023-02-28 | $3.32M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.63M derived: sum of 2 quarters · filed 2021-11-09 | $1.67M 10-Q · filed 2021-11-09 | $2.98M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $20.00K 10-Q · filed 2021-08-05 | $1.33M derived: sum of 3 quarters · filed 2022-03-01 | $2.03M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $37.00K 10-Q · filed 2021-05-06 | $1.35M derived: sum of 2 quarters · filed 2022-03-01 | $2.05M derived: sum of 3 quarters · filed 2022-03-01 | $1.22M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.01M derived: sum of 2 quarters · filed 2022-03-01 | $1.18M derived: sum of 3 quarters · filed 2022-03-01 | $1.74M 10-K · filed 2022-03-01 |
| 2019-09-30 | $699.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$131.00K derived: sum of 2 quarters · filed 2020-11-04 | $426.00K 10-Q · filed 2020-11-04 | -$36.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$830.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$273.00K 10-Q · filed 2020-08-06 | -$735.00K derived: sum of 3 quarters · filed 2021-02-25 | -$1.42M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $557.00K 10-Q · filed 2020-05-08 | $95.00K derived: sum of 2 quarters · filed 2021-02-25 | -$587.00K derived: sum of 3 quarters · filed 2021-02-25 | -$1.55M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$1.14M derived: sum of 2 quarters · filed 2021-02-25 | -$2.10M derived: sum of 3 quarters · filed 2021-02-25 | -$1.93M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$1.64M derived: sum of 2 quarters · filed 2019-10-31 | -$1.46M 10-Q · filed 2019-10-31 | -$2.10M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$959.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$782.00K 10-Q · filed 2019-08-01 | -$1.42M derived: sum of 3 quarters · filed 2020-02-27 | -$1.70M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $177.00K 10-Q · filed 2019-05-02 | -$456.00K derived: sum of 2 quarters · filed 2020-02-27 | -$738.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.39M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$633.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$915.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.21M derived: sum of 3 quarters · filed 2020-02-27 | $1.01M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.85M derived: sum of 2 quarters · filed 2018-11-06 | $1.65M 10-Q · filed 2018-11-06 | $1.45M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.93M 10-Q · filed 2018-08-08 | $1.73M derived: sum of 3 quarters · filed 2019-02-27 | $2.72M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$201.00K 10-Q · filed 2018-05-04 | -$399.00K derived: sum of 2 quarters · filed 2019-02-27 | $592.00K derived: sum of 3 quarters · filed 2019-02-27 | |
| 2016-12-31 | -$198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $793.00K derived: sum of 2 quarters · filed 2019-02-27 | $3.31M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $991.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.50M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $2.51M 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |